BOLD vs OBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BOLD Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boundless Bio, Inc. Common Stock (BOLD) driven by superior Growth & Margin, Momentum & Technical while OBIO counters with relative strength in Options & Structure. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OBIO at N/M Forward P/E and -195.4% operating margin (-89.4% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OBIO sits in CONSOLIDATION (21st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BOLD | OBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $56.2M | $550.9M | Larger Scale | OBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -89.4% | Higher Growth | BOLD |
| Operating Margin (TTM) Profitability | 0.0% | -195.4% | Higher Margin | BOLD |
| Net Profit Margin Profitability | 0.0% | -182.5% | Higher Margin | BOLD |
| Return on Equity (ROE) Capital Efficiency | -64.6% | -182.3% | Higher ROE | BOLD |
| 52-Week Range Position Momentum | 62% ($1โ$3) | 72% ($3โ$8) | Stronger Trend | OBIO |
| Beta / 30D Volatility Risk Regime | -0.08ฮฒ ยท 28% Vol | 1.18ฮฒ ยท 88% Vol | Lower Realized Risk | BOLD |
| Unified Institutional Score Composite Signal | 36.8 / 100 (SELL) | 41.1 / 100 (SELL) | Higher Composite | OBIO |